January 2006
Volume 5

Center for Cancer Research: Frontiers in Science

 

  CCR Home Printer-Friendly Article   Download PDF* Send Feedback Issue Archive

Contents

 
Translational Immunology Related to Cancer: Meeting Highlights Human T-Cell Leukemia/Lymphoma Virus Type 1: Playing Hide and Seek In Situ Analyses of Genome Instability in Breast Cancer Chromatin Function: A Network of Competitive Interactions Between Nucleosome Binding Proteins Distinct Regions of the IL-7 Receptor Regulate Different Bcl-2 Family Members Involvement of Chaperones in the Control of DNA Replication of Bacterial Plasmids An Unliganded Thyroid Hormone Nuclear β Receptor Induces Pituitary Tumors Altered Localization of RXRα Coincides with Loss of Retinoid Responsiveness in Human Breast Cancer Important Information

National Cancer Institute

 

*To download a copy
of Acrobat Reader,
click here.

Important Information

Administrative Links

Instant Messaging at NIH

As of October 12, 2005, registration is required to use instant messaging (IM) to communicate with contacts outside the NIH. Because IM is potentially vulnerable to several types of security and privacy incidents, including password stealing and the introduction of worms, viruses, and other malicious software, NIH IM Policy requires that all IM screen names be linked to the network account of each NIH user. Register your IM screen name.

New NCI A76 Web Site

The Office of Management Analysis has restructured and updated its A76 Web site. It now includes frequently asked questions (FAQs), a glossary of terms, contact information, and links to A76-related articles and videocasts. Visit the new Web site.

New Required Intramural Acknowledgement in Publications Will Aid in Tracking of Intramural Contributions to Science

As of July 23, 2005, The NIH Office of Intramural Research requires that all intramural scientists include in the acknowledgements section of all of their publications the following statement: “This research was supported [in part] by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.”

The wording should be precisely as stated since it will be used to track the publications. Any divergence from this wording will hinder the tracking and lead to possible exclusion of the publication. The [in part] should be removed when the research was fully funded by intramural research.

NIH intramural research makes a large contribution to the world of science. However, that contribution is not always acknowledged or even known, whereas extramural contributions are, and have always been, carefully tracked.

Therefore, the reasons for this new requirement are two fold: First, it will allow for tracking which publications come from intramural scientists despite variation in the way journals report addresses of co-authors. Second, this acknowledgement will highlight the important role that the intramural program plays in a great variety of innovative and collaborative research. As you know, scientists supported with extramural funds already are required to acknowledge NIH in their publications. Any questions should be directed to Tracy Thompson (thompstr@mail.nih.gov).

Scientific Advisory Committee

If you have scientific news of interest to the CCR research community, please contact one of the scientific advisors (below) responsible for your areas of research.

Biotechnology Resources

David J. Goldstein, PhD
dg187w@nih.gov
Tel: 301-496-4347

David J. Munroe, PhD
dm368n@nih.gov
Tel: 301-846-1697

Carcinogenesis, Cancer and Cell Biology, Tumor Biology

Joseph A. DiPaolo, PhD
jd81a@nih.gov
Tel: 301-496-6441

Stuart H. Yuspa, MD
sy12j@nih.gov
Tel: 301-496-2162

Clinical Research

Frank M. Balis, MD
fb2y@nih.gov
Tel: 301-496-0085

Caryn Steakley, RN, MSW
cs397r@nih.gov
Tel: 301-435-3685

Immunology

Jonathan D. Ashwell, MD
ja9s@nih.gov
Tel: 301-496-4931

Jay A. Berzofsky, MD, PhD
jb4q@nih.gov
Tel: 301-496-6874

Molecular Biology/
Developmental Biology

Carl Wu, PhD
cw1m@nih.gov
Tel: 301-496-3029

Structural Biology/Chemistry

Larry K. Keefer, PhD
keefer@ncifcrf.gov
Tel: 301-846-1467

Christopher J. Michejda, PhD
cm304t@nih.gov
Tel: 301-846-1216

Sriram Subramaniam, PhD
ss512h@nih.gov
Tel: 301-594-2062

Translational Research

Anita B. Roberts, PhD
ar40e@nih.gov
Tel: 301-496-6108

Elise C. Kohn, MD
ek1b@nih.gov
Tel: 301-402-2726

Virology

Vinay K. Pathak, PhD
vp63m@nih.gov
Tel: 301-846-1710

John T. Schiller, PhD
js153g@nih.gov
Tel: 301-496-6539

CCR Frontiers in Science—Staff

Center for Cancer Research

Robert H. Wiltrout, PhD, Director
Lee J. Helman, MD, Acting Scientific Director for Clinical Research
Frank M. Balis, MD, Clinical Director
L. Michelle Bennett, PhD, Associate Director for Science

Deputy Directors

H. Richard Alexander, Jr., MD
Douglas R. Lowy, MD
Jeffrey N. Strathern, PhD
Stuart H. Yuspa, MD

Editorial Staff

Tracy Thompson, Editor-in-Chief
Sue Fox, BA/BSW, Senior Editor
Lamont Williams, Managing Editor *
Ave Cline, Editor
Terry Taylor, Copy Editor *
Amy Schneider, Copy Editor (Web) *
Rob Wald, Publications Manager *
Michael Fleishman, Graphic Artist *

* Palladian Partners, Inc.

back to top